Acute cellular allograft rejection in homozygous CCR5 Δ32 patients after renal transplantation

Transplantation

Volumn 84, Issue 4, 2007, Pages 559-561

  Steinmetz, Oliver M ^a   Fischereder, Michael ^b   Weiss, Max ^b   Helmchen, Udo ^a   Stahl, Rolf A K ^a   Panzer, Ulf ^a,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

GENE MUTATION; GENOTYPE; GRAFT SURVIVAL; HOMOZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

GENETIC SCREENING; GRAFT REJECTION; HOMOZYGOTE; HUMANS; KIDNEY TRANSPLANTATION; MUTATION; RECEPTORS, CCR5; T-LYMPHOCYTES;

EID: 34548151611     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000279004.60372.ef     Document Type: Letter

References (7)

1. Colvin BL, Thomson AW. Chemokines, their receptors, and transplant outcome. Transplantation 2002; 74: 149.
2. Panzer U, Reinking RR, Steinmetz OM, et al. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation 2004; 78: 1341.
3. Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001; 357: 1758.
4. Molon B, Gri G, Bettella M, et al. T cell costimulation by chemokine receptors. Nat Immunol 2005; 6: 465.
5. Castellino F, Huang AY, Altan-Bonnet G, et al. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 2006; 440: 890.
6. Fatkenheuer G, Pozniak AL, Johnson MA, et al. Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med 2005; 11: 1170.
7. Hancock WW, Lu B, Gao W, et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000; 192: 1515.